172 related articles for article (PubMed ID: 25732227)
1. Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.
Olivares O; Vasseur S
Int J Cancer; 2016 Feb; 138(4):787-96. PubMed ID: 25732227
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways.
Guillaumond F; Iovanna JL; Vasseur S
Arch Biochem Biophys; 2014 Mar; 545():69-73. PubMed ID: 24393743
[TBL] [Abstract][Full Text] [Related]
3. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer cell metabolism in pancreatic adenocarcinoma.
Cohen R; Neuzillet C; Tijeras-Raballand A; Faivre S; de Gramont A; Raymond E
Oncotarget; 2015 Jul; 6(19):16832-47. PubMed ID: 26164081
[TBL] [Abstract][Full Text] [Related]
5. Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.
Xiang J; Liu L; Wang W; Xu H; Wu C; Xu J; Liu C; Long J; Ni Q; Yu X
Cancer Lett; 2015 Apr; 359(2):165-8. PubMed ID: 25617800
[TBL] [Abstract][Full Text] [Related]
6. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
[TBL] [Abstract][Full Text] [Related]
7. Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma.
Rai V; Agrawal S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198082
[TBL] [Abstract][Full Text] [Related]
8. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.
Kamphorst JJ; Nofal M; Commisso C; Hackett SR; Lu W; Grabocka E; Vander Heiden MG; Miller G; Drebin JA; Bar-Sagi D; Thompson CB; Rabinowitz JD
Cancer Res; 2015 Feb; 75(3):544-53. PubMed ID: 25644265
[TBL] [Abstract][Full Text] [Related]
9. Exploiting pancreatic cancer metabolism: challenges and opportunities.
De Santis MC; Bockorny B; Hirsch E; Cappello P; Martini M
Trends Mol Med; 2024 Jun; 30(6):592-604. PubMed ID: 38604929
[TBL] [Abstract][Full Text] [Related]
10. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
[TBL] [Abstract][Full Text] [Related]
11. Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential.
Kong SC; Giannuzzo A; Novak I; Pedersen SF
Biochem Cell Biol; 2014 Dec; 92(6):449-59. PubMed ID: 25372771
[TBL] [Abstract][Full Text] [Related]
12. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Halbrook CJ; Lyssiotis CA
Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution.
Hernández-Muñoz I; Skoudy A; Real FX; Navarro P
Pancreatology; 2008; 8(4-5):462-9. PubMed ID: 18724072
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling and pancreatic tumor development.
Lauth M; Toftgård R
Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.
Ogunleye AO; Nimmakayala RK; Batra SK; Ponnusamy MP
Stem Cells; 2023 May; 41(5):417-430. PubMed ID: 36869789
[TBL] [Abstract][Full Text] [Related]
17. Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies.
Wang Z; Wu B; Nie G; Wei J; Li Y
Cancer Lett; 2023 Apr; 560():216138. PubMed ID: 36934836
[TBL] [Abstract][Full Text] [Related]
18. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
[TBL] [Abstract][Full Text] [Related]
19. Analyzing miRNAs in ductal adenocarcinomas of the pancreas.
Mees ST; Schleicher C; Mardin WA; Senninger N; Colombo-Benkmann M; Haier J
J Surg Res; 2011 Aug; 169(2):241-6. PubMed ID: 20080250
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?
Rooman I; Real FX
Gut; 2012 Mar; 61(3):449-58. PubMed ID: 21730103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
